Nevirapine plasma concentrations are associated with virologic response and hepatotoxicity in Chinese patients with HIV infection
about
Efavirenz Has the Highest Anti-Proliferative Effect of Non-Nucleoside Reverse Transcriptase Inhibitors against Pancreatic Cancer CellsBone turnover and bone mineral density in HIV-1 infected Chinese taking highly active antiretroviral therapy -a prospective observational study.Comparison of nevirapine plasma concentrations between lead-in and steady-state periods in Chinese HIV-infected patients.Pharmacokinetic interaction between nevirapine and nortriptyline in rats: inhibition of nevirapine metabolism by nortriptylinePlasma nevirapine concentrations predict virological and adherence failure in Kenyan HIV-1 infected patients with extensive antiretroviral treatment exposureEfficacy and safety of switching from nevirapine immediate-release twice daily to nevirapine extended-release once daily in virologically suppressed HIV-infected patients: a retrospective cohort study in Taiwan.Effect of Moringa oleifera Lam. leaf powder on the pharmacokinetics of nevirapine in HIV-infected adults: a one sequence cross-over studySub-therapeutic nevirapine concentration during antiretroviral treatment initiation among children living with HIV: Implications for therapeutic drug monitoring.Evaluating the association of single-nucleotide polymorphisms with tenofovir exposure in a diverse prospective cohort of women living with HIV.Lipid-based nutrient supplements do not affect efavirenz but lower plasma nevirapine concentrations in Ethiopian adult HIV patients.Population pharmacokinetics of nevirapine in Malaysian HIV patients: a non-parametric approach.Validation and clinical application of a method to quantify nevirapine in dried blood spots and dried breast-milk spots.Clinical and genetic determinants of nevirapine plasma trough concentration.
P2860
Q28548473-C2E1C9A8-179B-49C7-986D-6C1254DA927FQ31124706-4AC77890-6A6D-4D56-84EC-0439532336DBQ34566233-3FE72879-0CEE-4E71-A234-9A2FAC6B2349Q34597852-3E64680B-1375-46AB-AB7F-CCC127572988Q36290009-BB810AA4-05B0-4766-BC5F-390D1787CCC3Q36343668-4423ABDD-8A69-4506-9B6E-BE665CB09C04Q37697972-90EE3E01-09BD-4741-903E-BF95E7845E8AQ40075886-2B76488A-A5FF-4F46-B1CA-BCDD9047803EQ40219167-AC555025-7783-4A1E-9EF4-E25FAC9E4251Q40280595-03DB66B8-315E-40B8-83EA-29716709AC41Q40736787-CF765BA7-BDBC-4C44-86C7-F0791AD5137CQ46474927-95957D59-1566-4D05-8EB2-D4C1EFAC58FBQ55263551-180BD511-CAB8-4DD1-9785-ECB12AD31281
P2860
Nevirapine plasma concentrations are associated with virologic response and hepatotoxicity in Chinese patients with HIV infection
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Nevirapine plasma concentratio ...... se patients with HIV infection
@ast
Nevirapine plasma concentratio ...... se patients with HIV infection
@en
Nevirapine plasma concentratio ...... se patients with HIV infection
@nl
type
label
Nevirapine plasma concentratio ...... se patients with HIV infection
@ast
Nevirapine plasma concentratio ...... se patients with HIV infection
@en
Nevirapine plasma concentratio ...... se patients with HIV infection
@nl
prefLabel
Nevirapine plasma concentratio ...... se patients with HIV infection
@ast
Nevirapine plasma concentratio ...... se patients with HIV infection
@en
Nevirapine plasma concentratio ...... se patients with HIV infection
@nl
P2093
P2860
P1433
P1476
Nevirapine plasma concentratio ...... se patients with HIV infection
@en
P2093
Huijuan Kou
Lingyan Zuo
Taisheng Li
Yanling Li
Zhifeng Qiu
P2860
P304
P356
10.1371/JOURNAL.PONE.0026739
P407
P577
2011-01-01T00:00:00Z